| Year |
Citation |
Score |
| 2021 |
Saber W, Steinert P, Zhang MJ, Chen M, Pope A, Keating A, Wingard JR, Ballen K, Stiff P, Perales MA, Forman S, Champlin R, Langston A, Rudebeck M, Horowitz M. A prospective cohort study comparing long-term outcomes with and without palifermin in patients receiving hematopoietic cell transplantation for hematologic malignancies. Transplantation and Cellular Therapy. PMID 34224914 DOI: 10.1016/j.jtct.2021.06.028 |
0.314 |
|
| 2020 |
Weinhäuser I, Pereira-Martins DA, Ortiz C, Silveira DR, Simões LAA, Bianco TM, Araujo CL, Koury LC, Melo RAM, Bittencourt RI, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria AB, ... ... Keating A, et al. Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia. Cancers. 12. PMID 33120864 DOI: 10.3390/cancers12113134 |
0.351 |
|
| 2020 |
Thomé CH, Ferreira GA, Pereira-Martins DA, Dos Santos GA, Ortiz CA, de Souza LEB, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Coelho-Silva JL, Traina F, Koury LC, ... ... Keating A, et al. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports. 10: 10315. PMID 32587277 DOI: 10.1038/S41598-020-66223-2 |
0.397 |
|
| 2020 |
Tang C, Espin-Garcia O, Prica A, Kurkreti V, Kridel R, Keating A, Patriquin CJ, Kuruvilla J, Crump M. Efficacy and safety of stem cell mobilization following gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy in patients with relapsed or refractory lymphoma. Leukemia & Lymphoma. 1-8. PMID 32482114 DOI: 10.1080/10428194.2020.1762882 |
0.419 |
|
| 2020 |
Assouline S, Li S, Gisselbrecht C, Fogarty P, Hay A, van den Neste E, Shepherd LE, Schmitz N, Baetz T, Keating A, Robinson S, Seftel M, Stelitano C, Djurfeldt MS, Meyer R, et al. The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL. Blood Advances. 4: 2011-2017. PMID 32396614 DOI: 10.1182/Bloodadvances.2020001646 |
0.37 |
|
| 2020 |
Chapman L, Abdi J, Galvez-Peisl S, Keating A. Immunophenotypic and functional characterisation of Mesodermal Killer (MK) cells: a novel cell type and potential cellular therapy for cancer Cytotherapy. 22. DOI: 10.1016/J.Jcyt.2020.03.226 |
0.414 |
|
| 2020 |
Krieger E, Sivagnanaling UU, Webb C, Roberts CH, Broadway D, Wiedl CM, Romee R, Keating A, Qayyum R, Toor AA. Hematopoietic Cell Transplantation Donor Selection Reimagined: KIR-KIR Ligand Interactions and a Formalized Donor Risk Index Effective at Predicting Survival Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.569 |
0.355 |
|
| 2019 |
Krieger E, Sabo R, Moezzi S, Cain C, Roberts C, Kimball P, Chesney A, McCarty J, Keating A, Romee R, Wiedl C, Qayyum R, Toor A. Killer Immunoglobulin-like Receptor-Ligand Interactions Predict Clinical Outcomes Following Unrelated Donor Transplants. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31676338 DOI: 10.1016/J.Bbmt.2019.10.016 |
0.375 |
|
| 2019 |
Williams BA, Law A, Hunyadkurti J, Desilets S, Leyton JV, Keating A. Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats. Journal of Clinical Medicine. 8. PMID 31434267 DOI: 10.3390/Jcm8081261 |
0.348 |
|
| 2019 |
Lucena-Araujo AR, Coelho-Silva JL, Pereira-Martins DA, Silveira DR, Koury LCA, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria AB, Kerbauy FR, Chauffaille ML, Bendit I, ... ... Keating A, et al. Combining gene mutation with gene expression analysis improves outcomes prediction in acute promyelocytic leukemia. Blood. PMID 31292112 DOI: 10.1182/Blood.2019000239 |
0.325 |
|
| 2019 |
Raileanu VN, Whiteley J, Chow T, Kollara A, Mohamed A, Keating A, Rogers IM. Banking Mesenchymal Stromal Cells from Umbilical Cord Tissue: Large Sample Size Analysis Reveals Consistency Between Donors. Stem Cells Translational Medicine. PMID 31219684 DOI: 10.1002/Sctm.19-0022 |
0.428 |
|
| 2019 |
Hu CD, Kosaka Y, Marcus P, Rashedi I, Keating A. Differential immunomodulatory effects of human bone marrow-derived mesenchymal stromal cells on natural killer cells. Stem Cells and Development. PMID 31122145 DOI: 10.1089/Scd.2019.0059 |
0.411 |
|
| 2019 |
Wang S, Su X, Xu M, Xiao X, Li X, Li H, Keating A, Zhao RC. Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway. Stem Cell Research & Therapy. 10: 117. PMID 30971292 DOI: 10.1186/S13287-019-1220-2 |
0.335 |
|
| 2019 |
Chahal J, Gómez-Aristizábal A, Shestopaloff K, Bhatt S, Chaboureau A, Fazio A, Chisholm J, Weston A, Chiovitti J, Keating A, Kapoor M, Ogilvie-Harris DJ, Syed KA, Gandhi R, Mahomed NN, et al. Bone Marrow Mesenchymal Stromal Cells in Patients with Osteoarthritis Results in Overall Improvement in Pain and Symptoms and Reduces Synovial Inflammation. Stem Cells Translational Medicine. PMID 30964245 DOI: 10.1002/Sctm.18-0183 |
0.356 |
|
| 2019 |
Kim C, Keating A. Cell Therapy for Knee Osteoarthritis: Mesenchymal Stromal Cells. Gerontology. 1-5. PMID 30897578 DOI: 10.1159/000496605 |
0.312 |
|
| 2019 |
Meier JA, Haque M, Fawaz M, Abdeen H, Coffey D, Towlerton A, Abdeen A, Toor A, Warren E, Reed J, Kanakry CG, Keating A, Luznik L, Toor AA. T Cell Repertoire Evolution After Allogeneic Bone Marrow Transplantation: An Organizational Perspective. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30677510 DOI: 10.1016/J.Bbmt.2019.01.021 |
0.416 |
|
| 2019 |
Ernst D, Williams BA, Wang XH, Yoon N, Kim KP, Chiu J, Luo ZJ, Hermans KG, Krueger J, Keating A. Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1. Blood Cancer Journal. 9: 6. PMID 30647406 DOI: 10.1038/S41408-018-0168-2 |
0.368 |
|
| 2019 |
Coso D, Keating A. Current Treatment of Chronic Myeloid Leukemia. Hematology (Amsterdam, Netherlands). 6: 1-17. PMID 27419598 DOI: 10.1080/10245332.2001.11746548 |
0.352 |
|
| 2019 |
Greenberger J, Keating A. Editorial on "Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective", Cheryl Hardy. Hematology (Amsterdam, Netherlands). 5: 389-390. PMID 11399638 |
0.305 |
|
| 2019 |
Greenberger J, Keating A. Introductory Commentary on Regulation of LFA-1 Expression by CD34+ Cells and Inducible Growth Factor Production by Stroma Enable Formation of Bone Marrow Compartments, Torensma et al. Hematology (Amsterdam, Netherlands). 5: 293. PMID 11399625 DOI: 10.1080/10245332.2000.11746520 |
0.324 |
|
| 2019 |
Krieger E, Sivagnanaling U, Webb K, Broadway D, Roberts C, McCarty JM, Wiedl CM, Romee R, Keating A, Qayyum R, Toor AA. Hematopoietic Cell Transplantation Donor Selection Reimagined: KIR-KIR Ligand Interactions and a Formalized Donor Risk Index Effective at Predicting Survival Blood. 134: 4616-4616. DOI: 10.1182/Blood-2019-129384 |
0.386 |
|
| 2019 |
Assouline S, Li S, Gisselbrecht C, Fogarty P, Hay AE, Neste EVD, Shepherd LE, Schmitz N, Baetz T, Keating A, Robinson S, Seftel MD, Stelitano C, Djurfeldt MS, Meyer R, et al. Event-Free Survival As a Surrogate for Overall Survival in Relapsed DLBCL after Autologous Transplant: A Subgroup Analysis of LY.12 and Coral Blood. 134: 768-768. DOI: 10.1182/Blood-2019-124879 |
0.34 |
|
| 2019 |
Medin JA, Khan A, Huang J, Barber D, Anthony Rupar C, Auray-Blais C, Fraser G, Fowler DH, Keating A, West ML, Foley R. FACTs Fabry gene therapy clinical trial: Two-year data Molecular Genetics and Metabolism. 126: S99. DOI: 10.1016/J.Ymgme.2018.12.248 |
0.424 |
|
| 2019 |
Tang C, Espin-Garcia O, Prica A, Kukreti V, Kridel R, Keating A, Kuruvilla J, Crump M. EFFICIENCY AND SAFETY OF STEM CELL MOBILIZATION FOLLOWING GDP SALVAGE IN PATIENTS WITH RELAPSED OR REFRACTORY LYMPHOMA Hematological Oncology. 37: 437-438. DOI: 10.1002/Hon.112_2631 |
0.392 |
|
| 2018 |
Li H, Zhu L, Chen H, Li T, Han Q, Wang S, Yao X, Feng H, Fan L, Gao S, Boyd R, Cao X, Zhu P, Li J, Keating A, et al. Generation of Functional Hepatocytes from Human Adipose-Derived MYC KLF4 GMNN Stem Cells Analyzed by Single-Cell RNA-Seq Profiling. Stem Cells Translational Medicine. PMID 30272835 DOI: 10.1002/Sctm.17-0273 |
0.421 |
|
| 2018 |
Filomeno PA, Kim KP, Yoon N, Rashedi I, Dayan V, Kandel RA, Wang XH, Felizardo TC, Berinstein E, Jelveh S, Filomeno A, Medin JA, Ferguson PC, Keating A. Human mesenchymal stromal cells do not promote recurrence of soft tissue sarcomas in mouse xenografts after radiation and surgery. Cytotherapy. PMID 30076069 DOI: 10.1016/J.Jcyt.2018.05.011 |
0.303 |
|
| 2018 |
Williams BA, Wang XH, Leyton JV, Maghera S, Deif B, Reilly RM, Minden MD, Keating A. CD16+NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice. Haematologica. PMID 29976748 DOI: 10.3324/Haematol.2017.187385 |
0.37 |
|
| 2018 |
Thanarajasingam G, Minasian LM, Baron F, Cavalli F, De Claro RA, Dueck AC, El-Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gribben J, Horowitz M, Ivy SP, Jacobson CA, Keating A, et al. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. The Lancet. Haematology. PMID 29907552 DOI: 10.1016/S2352-3026(18)30051-6 |
0.356 |
|
| 2018 |
Whiteley J, Chow T, Adissu H, Keating A, Rogers IM. Topical Application of Culture-Expanded CD34+ Umbilical Cord Blood Cells from Frozen Units Accelerates Healing of Diabetic Skin Wounds in Mice. Stem Cells Translational Medicine. PMID 29752867 DOI: 10.1002/Sctm.17-0302 |
0.343 |
|
| 2018 |
Chiu J, Ernst DM, Keating A. Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma. Frontiers in Immunology. 9: 267. PMID 29491867 DOI: 10.3389/Fimmu.2018.00267 |
0.348 |
|
| 2018 |
Pereira-Martins DA, Ortiz C, Franca-Neto PL, Weinhäuser I, Schiavinato JL, Palma PVB, Bonaldo C, Koury LCA, Nascimento MCD, Melo RAM, Bittencourt R, Pagnano KBB, Pasquini R, Fagundes EM, Gloria ABF, ... ... Keating A, et al. Metformintreatment Overcomes ATRA-Resistance in Acute Promyelocytic Leukemia and Increases FOXO3A Expression Blood. 132: 1532-1532. DOI: 10.1182/Blood-2018-99-115068 |
0.395 |
|
| 2017 |
Falcone U, Jiang H, Bashir S, Tsang R, Kukreti V, Keating A, Crump M, Kuruvilla J. Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma. Bone Marrow Transplantation. PMID 29269808 DOI: 10.1038/S41409-017-0054-8 |
0.47 |
|
| 2017 |
Yannarelli G, Pacienza N, Montanari S, Santa-Cruz D, Viswanathan S, Keating A. OCT4 expression mediates partial cardiomyocyte reprogramming of mesenchymal stromal cells. Plos One. 12: e0189131. PMID 29216265 DOI: 10.1371/Journal.Pone.0189131 |
0.71 |
|
| 2017 |
Williams BA, Law AD, Routy B, denHollander N, Gupta V, Wang XH, Chaboureau A, Viswanathan S, Keating A. A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy. Oncotarget. 8: 89256-89268. PMID 29179517 DOI: 10.18632/Oncotarget.19204 |
0.42 |
|
| 2017 |
Rashedi I, Talele N, Wang XH, Hinz B, Radisic M, Keating A. Collagen scaffold enhances the regenerative properties of mesenchymal stromal cells. Plos One. 12: e0187348. PMID 29088264 DOI: 10.1371/Journal.Pone.0187348 |
0.302 |
|
| 2017 |
Williams BA, Law AD, Routy B, denHollander N, Gupta V, Wang XH, Chaboureau A, Viswanathan S, Keating A. A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy. Oncotarget. PMID 28732386 DOI: 10.18632/oncotarget.19204 |
0.307 |
|
| 2017 |
Huang J, Khan A, Au BC, Barber DL, López-Vásquez L, Prokopishyn NL, Boutin M, Rothe M, Rip JW, Abaoui M, Nagree MS, Dworski S, Schambach A, Keating A, West ML, et al. Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34(+) Cells for Correction of Fabry Disease. Molecular Therapy. Methods & Clinical Development. 5: 241-258. PMID 28603745 DOI: 10.1016/J.Omtm.2017.05.003 |
0.411 |
|
| 2017 |
Davies JE, Walker JT, Keating A. Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells. Stem Cells Translational Medicine. PMID 28488282 DOI: 10.1002/Sctm.16-0492 |
0.383 |
|
| 2016 |
Locke FL, Pidala J, Storer B, Martin PJ, Pulsipher MA, Chauncey TR, Jacobsen N, Kröger N, Walker I, Light S, Shaw BE, Beato F, Laport GG, Nademanee A, Keating A, et al. CD25 Blockade Delays Treg Reconstitution and Does Not Prevent Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28007665 DOI: 10.1016/J.Bbmt.2016.12.624 |
0.421 |
|
| 2016 |
Rashedi I, Gomez-Aristizábal A, Wang XH, Viswanathan S, Keating A. TLR3 or TLR4 Activation Enhances MSC-Mediated Treg Induction via Notch Signaling. Stem Cells (Dayton, Ohio). PMID 27571579 DOI: 10.1002/Stem.2485 |
0.3 |
|
| 2016 |
Keating A, Spinolo J. Highlights of the Fifth International Symposium on Autologous Bone Marrow Transplantation Omaha, Nebraska, August 23-25, 1990. Leukemia & Lymphoma. 4: 423-4. PMID 27467678 DOI: 10.3109/10428199109068096 |
0.386 |
|
| 2016 |
Angelov L, Brandwein JM, Baker MA, Scott JG, Sutton DM, Keating A. Results of Therapy for Acute Myeloid Leukemia in First Relapse. Leukemia & Lymphoma. 6: 15-24. PMID 27457571 DOI: 10.3109/10428199109064874 |
0.356 |
|
| 2016 |
Greenberger J, Keating A. Introductory Commentary on Gap Junction Intercellular Communication is Likely to be Involved in Regulation of Stroma-dependent Proliferation of Hematopoietic Stem Cells Ploemacher R. Et Al. Hematology (Amsterdam, Netherlands). 5: 131. PMID 27427268 DOI: 10.1080/10245332.2000.11746497 |
0.32 |
|
| 2016 |
Greenberger J, Keating A. The Hematopoietic Microenvironment. Hematology (Amsterdam, Netherlands). 5: 129-30. PMID 27427267 DOI: 10.1080/10245332.2000.11746496 |
0.412 |
|
| 2016 |
Greenberger J, Keating A. Editorial on "Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective", Cheryl Hardy. Hematology (Amsterdam, Netherlands). 5: 389-90. PMID 27420930 DOI: 10.1080/10245332.2000.11746534 |
0.418 |
|
| 2016 |
Keating A. Phenotypic and Functional Characterization of Human Marrow Vascular Stromal Cells. Hematology (Amsterdam, Netherlands). 4: 255. PMID 27420554 DOI: 10.1080/10245332.1999.11746450 |
0.351 |
|
| 2016 |
Greenberger J, Keating A. Stromal Cell Types: Characterization and Function In Situ and In Vitro. Hematology (Amsterdam, Netherlands). 4: 239-40. PMID 27420553 DOI: 10.1080/10245332.1999.11746448 |
0.339 |
|
| 2016 |
Greenberger J, Keating A. Characterization of Bone Marrow Stromal Cells. Hematology (Amsterdam, Netherlands). 4: 237. PMID 27420552 DOI: 10.1080/10245332.1999.11746447 |
0.369 |
|
| 2016 |
Greenberger J, Keating A. Editorial Comment: Heterogeneity of Bone Marrow Stromal Cells Editorial Comment on Dr. Waller's Paper. Hematology (Amsterdam, Netherlands). 4: 45-6. PMID 27414189 DOI: 10.1080/10245332.1999.11746429 |
0.356 |
|
| 2016 |
Deschaseaux F, Remy-Martin JP, Keating A, Hervé P, Charbord P. Adhesion of Hematopoietic Precursors to Human Stroma: Studies Using Normal Marrow Stromal Myofibroblasts and a Stromal Cell Line Transformed by SV40. Hematology (Amsterdam, Netherlands). 3: 401-17. PMID 27414085 DOI: 10.1080/10245332.1998.11746415 |
0.372 |
|
| 2016 |
Fouillard L, Matthews KE, Guinn BA, Branch DR, Keating A. Expression of Factor IX cDNA Introduced into Human Marrow Stromal Cells by Electroporation. Hematology (Amsterdam, Netherlands). 3: 347-54. PMID 27414078 DOI: 10.1080/10245332.1998.11746408 |
0.382 |
|
| 2016 |
Meppelink AM, Wang XH, Bradica G, Barron K, Hiltz K, Liu XH, Goldman SM, Vacanti JP, Keating A, Hoganson DM. Rapid isolation of bone marrow mesenchymal stromal cells using integrated centrifuge-based technology. Cytotherapy. 18: 729-39. PMID 27173749 DOI: 10.1016/J.Jcyt.2016.03.291 |
0.37 |
|
| 2016 |
Dayan V, Sotelo V, Delfina V, Delgado N, Rodriguez C, Suanes C, Langhain M, Ferrando R, Keating A, Benech A, Touriño C. Human Mesenchymal Stromal Cells Improve Cardiac Perfusion in an Ovine Immunocompetent Animal Model. Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research. 1-8. PMID 26891475 DOI: 10.3109/08941939.2015.1128997 |
0.339 |
|
| 2016 |
Boissel L, Klingemann H, Campbell K, Nichols K, Toneguzzo F, Marcus P, Williams B, Keating A, Soon-Shiong P. Abstract 2302: An ‘off the shelf,’ GMP-grade, IL-2-independent NK cell line expressing the high-affinity Fc-receptor to augment antibody therapeutics Cancer Research. 76: 2302-2302. DOI: 10.1158/1538-7445.Am2016-2302 |
0.392 |
|
| 2016 |
Viswanathan S, Bhatt S, Gómez-Aristizábal A, Chaboureau A, Weston A, Fazio A, Kapoor M, Naraghi A, Mahomed N, Marshall W, Keating A, Ogilvie-Harris D, Chahal J. Human Autologous Mesenchymal Stromal Cells for the Treatment of Mid to Late Stage Knee Osteoarthritis—A Phase I Pilot Study Cytotherapy. 18: S132. DOI: 10.1016/J.Jcyt.2016.03.256 |
0.301 |
|
| 2015 |
Leyton JV, Gao C, Williams B, Keating A, Minden M, Reilly RM. A radiolabeled antibody targeting CD123(+) leukemia stem cells - initial radioimmunotherapy studies in NOD/SCID mice engrafted with primary human AML. Leukemia Research Reports. 4: 55-9. PMID 26500848 DOI: 10.1016/J.Lrr.2015.07.003 |
0.388 |
|
| 2015 |
Satwani P, Ahn KW, Carreras J, Abdel-Azim H, Cairo MS, Cashen A, Chen AI, Cohen JB, Costa LJ, Dandoy C, Fenske TS, Freytes CO, Ganguly S, Gale RP, Ghosh N, ... ... Keating A, et al. A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma. Bone Marrow Transplantation. PMID 26237164 DOI: 10.1038/Bmt.2015.177 |
0.341 |
|
| 2015 |
Montanari S, Dayan V, Yannarelli G, Billia F, Viswanathan S, Connelly KA, Keating A. Mesenchymal stromal cells improve cardiac function and left ventricular remodeling in a heart transplantation model. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. PMID 26234284 DOI: 10.1016/J.Healun.2015.05.008 |
0.724 |
|
| 2015 |
Fujii H, Luo ZJ, Kim HJ, Newbigging S, Gassas A, Keating A, Egeler RM. Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation. Plos One. 10: e0133216. PMID 26176698 DOI: 10.1371/Journal.Pone.0133216 |
0.39 |
|
| 2015 |
Behbahan IS, Keating A, Gale RP. Bone Marrow Therapies for Chronic Heart Disease. Stem Cells (Dayton, Ohio). 33: 3212-27. PMID 26086629 DOI: 10.1002/Stem.2080 |
0.394 |
|
| 2015 |
Weiss DJ, Chambers D, Giangreco A, Keating A, Kotton D, Lelkes PI, Wagner DE, Prockop DJ. An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases. Annals of the American Thoracic Society. 12: S79-97. PMID 25897748 DOI: 10.1513/Annalsats.201502-086St |
0.314 |
|
| 2015 |
Liu X, Ren S, Ge C, Cheng K, Zenke M, Keating A, Zhao RC. Sca-1+Lin-CD117- mesenchymal stem/stromal cells induce the generation of novel IRF8-controlled regulatory dendritic cells through Notch-RBP-J signaling. Journal of Immunology (Baltimore, Md. : 1950). 194: 4298-308. PMID 25825436 DOI: 10.4049/Jimmunol.1402641 |
0.403 |
|
| 2015 |
Gesundheit B, Ashwood P, Keating A, Naor D, Melamed M, Rosenzweig JP. Therapeutic properties of mesenchymal stem cells for autism spectrum disorders. Medical Hypotheses. 84: 169-77. PMID 25592283 DOI: 10.1016/J.Mehy.2014.12.016 |
0.331 |
|
| 2015 |
Sun Z, Wu J, Li SH, Zhang Y, Xaymardan M, Wen XY, Weisel RD, Keating A, Li RK. Uterine-derived stem cells reconstitute the bone marrow of irradiated mice. Stem Cells and Development. 24: 938-47. PMID 25434698 DOI: 10.1089/Scd.2014.0478 |
0.467 |
|
| 2015 |
Bustos ML, Mura M, Hwang D, Ludkovski O, Wong AP, Keating A, Waddell TK. Depletion of bone marrow CCSP-expressing cells delays airway regeneration. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 561-9. PMID 25409745 DOI: 10.1038/Mt.2014.223 |
0.395 |
|
| 2015 |
Kuo KH, Callum JL, Panzarella T, Jacks LM, Brandwein J, Crump M, Curtis JE, Gupta V, Lipton JH, Minden MD, Sher GD, Schimmer AD, Schuh AC, Yee KW, Keating A, et al. A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis. British Journal of Haematology. 168: 384-94. PMID 25303497 DOI: 10.1111/Bjh.13146 |
0.308 |
|
| 2015 |
Williams B, Routy B, denHollander N, Wang X, Chaboureau A, Viswanathan S, Keating A. NK-92 Therapy Is Well Tolerated, Has Minimal Toxicity and Shows Efficacy in a Phase I Trial of Patients with Relapsed/Refractory Hematological Malignancies Relapsing after Autologous Stem Cell Transplantation Blood. 126: 4297-4297. DOI: 10.1182/Blood.V126.23.4297.4297 |
0.468 |
|
| 2015 |
Falcone U, Bashir S, Al-Farsi K, Watkins L, Turvey CD, Franke N, Keating A, Crump M, Kuruvilla J. Long-Term Results of Cytarabine-Containing Induction Followed By Consolidation with Autologous Stem Cell Transplant and Rituximab Maintenance As Primary Treatment for Mantle Cell Lymphoma Blood. 126: 1995-1995. DOI: 10.1182/Blood.V126.23.1995.1995 |
0.37 |
|
| 2014 |
Leyton JV, Williams B, Gao C, Keating A, Minden M, Reilly RM. MicroSPECT/CT imaging of primary human AML engrafted into the bone marrow and spleen of NOD/SCID mice using 111In-DTPA-NLS-CSL360 radioimmunoconjugates recognizing the CD123+ / CD131- epitope expressed by leukemia stem cells. Leukemia Research. 38: 1367-73. PMID 25278187 DOI: 10.1016/J.Leukres.2014.09.005 |
0.368 |
|
| 2014 |
Andrews PW, Cavagnaro J, Cavanagro J, Deans R, Feigal E, Feigel E, Horowitz E, Keating A, Rao M, Turner M, Wilmut I, Yamanaka S. Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Nature Biotechnology. 32: 724-6. PMID 25093882 DOI: 10.1038/Nbt.2973 |
0.378 |
|
| 2014 |
Montanari S, Wang XH, Yannarelli G, Dayan V, Berger T, Zocche L, Kobayashi E, Viswanathan S, Keating A. Development and characterization of a new inbred transgenic rat strain expressing DsRed monomeric fluorescent protein. Transgenic Research. 23: 779-93. PMID 25011565 DOI: 10.1007/S11248-014-9814-Z |
0.684 |
|
| 2014 |
Wang L, Han Q, Chen H, Wang K, Shan GL, Kong F, Yang YJ, Li YZ, Zhang X, Dong F, Wang Q, Xu D, Hu ZJ, Wang SH, Keating A, et al. Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis. Stem Cells and Development. 23: 2482-9. PMID 24835895 DOI: 10.1089/Scd.2013.0500 |
0.446 |
|
| 2014 |
Yannarelli G, Tsoporis JN, Desjardins JF, Wang XH, Pourdjabbar A, Viswanathan S, Parker TG, Keating A. Donor mesenchymal stromal cells (MSCs) undergo variable cardiac reprogramming in vivo and predominantly co-express cardiac and stromal determinants after experimental acute myocardial infarction. Stem Cell Reviews. 10: 304-15. PMID 24287730 DOI: 10.1007/S12015-013-9483-Y |
0.4 |
|
| 2014 |
Tsui H, Ghazarian M, Winer S, Adissu H, Dosch M, Reis MD, Winer D, Keating A. Sensory Neuropeptides Prime the Splenic Marginal Zone for Optimal Humoral Immunity Blood. 124: 4123-4123. DOI: 10.1182/Blood.V124.21.4123.4123 |
0.32 |
|
| 2014 |
Williams BA, Wang X, Routy B, Cheng R, Maghera S, Keating A. NK Cell Line Killing of Leukemia Cells Is Enhanced By Reverse Antibody Dependent Cell Mediated Cytotoxicity (R-ADCC) Via NKp30 and NKp44 and Target Fcγ Receptor II (CD32) Blood. 124: 2444-2444. DOI: 10.1182/Blood.V124.21.2444.2444 |
0.372 |
|
| 2014 |
Andrews PW, Cavanagro J, Deans R, Feigel E, Horowitz E, Keating A, Rao M, Turner M, Wilmut I, Yamanaka S. Erratum: Corrigendum: Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells Nature Biotechnology. 32: 1166-1166. DOI: 10.1038/Nbt1114-1166D |
0.309 |
|
| 2014 |
Fujii H, Luo Z, Wang X, Newbigging S, Keating A, Egeler RM. Establishment of Xenogeneic Lung Chronic Graft-Verus-Host Disease Mice Model Biology of Blood and Marrow Transplantation. 20: S266-S267. DOI: 10.1016/J.Bbmt.2013.12.449 |
0.378 |
|
| 2013 |
Behbahan IS, Keating A, Gale RP. Concise review: bone marrow autotransplants for liver disease? Stem Cells (Dayton, Ohio). 31: 2313-29. PMID 23939914 DOI: 10.1002/Stem.1510 |
0.41 |
|
| 2013 |
Zhou Y, Day A, Haykal S, Keating A, Waddell TK. Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway. Cytotherapy. 15: 1195-207. PMID 23845188 DOI: 10.1016/J.Jcyt.2013.05.009 |
0.4 |
|
| 2013 |
Viswanathan S, Rao M, Keating A, Srivastava A. Overcoming challenges to initiating cell therapy clinical trials in rapidly developing countries: India as a model. Stem Cells Translational Medicine. 2: 607-13. PMID 23836804 DOI: 10.5966/Sctm.2013-0019 |
0.378 |
|
| 2013 |
Cuende N, Herrera C, Keating A. When the best is the enemy of the good: the case of bone-marrow mononuclear cells to treat ischemic syndromes. Haematologica. 98: 323-4. PMID 23449595 DOI: 10.3324/Haematol.2013.086231 |
0.351 |
|
| 2013 |
Villa D, Crump M, Keating A, Panzarella T, Feng B, Kuruvilla J. Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 1603-9. PMID 23425946 DOI: 10.1093/Annonc/Mdt029 |
0.429 |
|
| 2013 |
Siegers GM, Ribot EJ, Keating A, Foster PJ. Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI. Cancer Immunology, Immunotherapy : Cii. 62: 571-83. PMID 23100099 DOI: 10.1007/S00262-012-1353-Y |
0.345 |
|
| 2013 |
Yannarelli G, Pacienza N, Cuniberti L, Medin J, Davies J, Keating A. Brief report: The potential role of epigenetics on multipotent cell differentiation capacity of mesenchymal stromal cells. Stem Cells (Dayton, Ohio). 31: 215-20. PMID 23097343 DOI: 10.1002/Stem.1262 |
0.437 |
|
| 2013 |
Yannarelli G, Dayan V, Pacienza N, Lee CJ, Medin J, Keating A. Human umbilical cord perivascular cells exhibit enhanced cardiomyocyte reprogramming and cardiac function after experimental acute myocardial infarction. Cell Transplantation. 22: 1651-66. PMID 23043977 DOI: 10.3727/096368912X657675 |
0.396 |
|
| 2013 |
Keating A, DaSilva G, Pérez WS, Gupta V, Cutler CS, Ballen KK, Cairo MS, Camitta BM, Champlin RE, Gajewski JL, Lazarus HM, Lill M, Marks DI, Nabhan C, Schiller GJ, et al. Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research. Haematologica. 98: 185-92. PMID 22983587 DOI: 10.3324/Haematol.2012.062059 |
0.424 |
|
| 2013 |
Puig N, Wang L, Seshadri T, al-Farsi K, Keating A, Crump M, Kuruvilla J. Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma. Leukemia & Lymphoma. 54: 507-13. PMID 22897731 DOI: 10.3109/10428194.2012.719615 |
0.405 |
|
| 2013 |
Gangatharan SA, Kuruvilla J, Kukreti V, Keating A, Maganti M, Pintilie M, Crump M. Stem Cell Dose and Time To Engraftment Does Not Predict Outcome After Autologous Stem Cell Transplantation For Relapsed Aggressive NHL Blood. 122: 5542-5542. DOI: 10.1182/Blood.V122.21.5542.5542 |
0.461 |
|
| 2013 |
Paltser G, Adissu H, Dosch M, Keating A. Making “Sense” Of Persistent Polyclonal B Cell Lymphocytosis Blood. 122: 3500-3500. DOI: 10.1182/Blood.V122.21.3500.3500 |
0.312 |
|
| 2013 |
Kuruvilla J, Kouroukis CT, Benger A, Cheung MC, Berinstein NL, Couban S, Seftel MD, Howson-Jan K, Keating A, Federico M, Macdonald DA, Olney HJ, Rubinger M, Voralia M, Turner AR, et al. A Randomized Trial Of Rituximab Vs Observation Following Autologous Stem Cell Transplantation (ASCT) For Relapsed Or Refractory CD20-Positive B Cell Lymphoma: Final Results Of NCIC CTG LY.12 Blood. 122: 155-155. DOI: 10.1182/Blood.V122.21.155.155 |
0.33 |
|
| 2012 |
Liu X, Qu X, Chen Y, Liao L, Cheng K, Shao C, Zenke M, Keating A, Zhao RC. Mesenchymal stem/stromal cells induce the generation of novel IL-10-dependent regulatory dendritic cells by SOCS3 activation. Journal of Immunology (Baltimore, Md. : 1950). 189: 1182-92. PMID 22753940 DOI: 10.4049/Jimmunol.1102996 |
0.383 |
|
| 2012 |
Goda JS, Massey C, Kuruvilla J, Gospodarowicz MK, Wells W, Hodgson DC, Sun A, Keating A, Crump M, Tsang RW. Role of salvage radiation therapy for patients with relapsed or refractory hodgkin lymphoma who failed autologous stem cell transplant. International Journal of Radiation Oncology, Biology, Physics. 84: e329-35. PMID 22672755 DOI: 10.1016/J.Ijrobp.2012.04.007 |
0.37 |
|
| 2012 |
Dayan V, Yannarelli G, Filomeno P, Keating A. Human mesenchymal stromal cells improve scar thickness without enhancing cardiac function in a chronic ischaemic heart failure model. Interactive Cardiovascular and Thoracic Surgery. 14: 516-20. PMID 22361124 DOI: 10.1093/Icvts/Ivs048 |
0.352 |
|
| 2012 |
Swift BE, Williams BA, Kosaka Y, Wang XH, Medin JA, Viswanathan S, Martinez-Lopez J, Keating A. Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model. Haematologica. 97: 1020-8. PMID 22271890 DOI: 10.3324/Haematol.2011.054254 |
0.413 |
|
| 2012 |
Villa D, Seshadri T, Puig N, Massey C, Tsang R, Keating A, Crump M, Kuruvilla J. Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy. Haematologica. 97: 751-7. PMID 22180434 DOI: 10.3324/Haematol.2011.047670 |
0.358 |
|
| 2012 |
Telio D, Fernandes K, Ma C, Tsang R, Keating A, Crump M, Kuruvilla J. Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors. Leukemia & Lymphoma. 53: 836-41. PMID 22136378 DOI: 10.3109/10428194.2011.643404 |
0.425 |
|
| 2012 |
Khoury HJ, Kukreja M, Goldman JM, Wang T, Halter J, Arora M, Gupta V, Rizzieri DA, George B, Keating A, Gale RP, Marks DI, McCarthy PL, Woolfrey A, Szer J, et al. Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis. Bone Marrow Transplantation. 47: 810-6. PMID 21986636 DOI: 10.1038/Bmt.2011.194 |
0.415 |
|
| 2012 |
Keating A, Nolan E, Filshie R, Dev SB. Ex Vivo Stromal Cell Electroporation of Factor IX cDNA for Treatment of Hemophilia B. Methods in Molecular Medicine. 37: 359-68. PMID 21445754 DOI: 10.1385/1-59259-080-2:359 |
0.311 |
|
| 2012 |
Keating A, Toor P. In vitro clonal culture of human hematopoietic progenitor cells. Methods in Molecular Biology (Clifton, N.J.). 5: 339-46. PMID 21374137 DOI: 10.1385/0-89603-150-0:339 |
0.417 |
|
| 2012 |
Keating A, Toor P. Human long-term bone marrow culture. Methods in Molecular Biology (Clifton, N.J.). 5: 331-7. PMID 21374136 DOI: 10.1385/0-89603-150-0:331 |
0.312 |
|
| 2012 |
Locke FL, Pidala J, Storer B, Martin PJ, Pulsipher MA, Chauncey T, Jacobsen N, Kroeger N, Walker I, Territo MC, Light S, Laport GG, Nademanee A, Powles R, Keating A, et al. The Anti-CD25 Antibody Daclizumab Delays Treg Reconstitution, Promotes CD4 Memory, and Does Not Prevent Acute or Chronic Gvhd After Allogeneic Stem Cell Transplantation Blood. 120: 4195-4195. DOI: 10.1182/Blood.V120.21.4195.4195 |
0.369 |
|
| 2012 |
Williams BA, Wang X, Maghera S, Leyton JV, Reilly R, Keating A. Irradiated NK-92 Targets AML Leukemic Stem Cells in Vivo and Gene-Modified CD16+NK-92 Mediates Antibody Dependent Cell Mediated Cytotoxicity (ADCC) Against CD123+ Cells Blood. 120: 1909-1909. DOI: 10.1182/Blood.V120.21.1909.1909 |
0.386 |
|
| 2011 |
Viswanathan S, Keating A. Overcoming the challenges of conducting translational research in cell therapy. Frontiers of Medicine. 5: 333-5. PMID 22198744 DOI: 10.1007/S11684-011-0166-2 |
0.341 |
|
| 2011 |
Dayan V, Yannarelli G, Billia F, Filomeno P, Wang XH, Davies JE, Keating A. Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Research in Cardiology. 106: 1299-310. PMID 21901289 DOI: 10.1007/S00395-011-0221-9 |
0.325 |
|
| 2011 |
Degousee N, Kelvin DJ, Geisslinger G, Hwang DM, Stefanski E, Wang XH, Danesh A, Angioni C, Schmidt H, Lindsay TF, Gelb MH, Bollinger J, Payré C, Lambeau G, Arm JP, ... Keating A, et al. Group V phospholipase A2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia. The Journal of Biological Chemistry. 286: 35650-62. PMID 21849511 DOI: 10.1074/Jbc.M111.262733 |
0.32 |
|
| 2011 |
Mothe AJ, Bozkurt G, Catapano J, Zabojova J, Wang X, Keating A, Tator CH. Intrathecal transplantation of stem cells by lumbar puncture for thoracic spinal cord injury in the rat. Spinal Cord. 49: 967-73. PMID 21606931 DOI: 10.1038/Sc.2011.46 |
0.332 |
|
| 2011 |
Alajez NM, Wang W, Biswas D, Teh A, Sutherland R, Pintilie M, Minden M, Messner H, Fyles A, Gospodarowicz M, Keating A, Liu FF. The effect of local breast radiotherapy on circulating CD34(+) cells. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 100: 304-7. PMID 21316784 DOI: 10.1016/J.Radonc.2011.01.003 |
0.332 |
|
| 2011 |
Siegers GM, Dhamko H, Wang XH, Mathieson AM, Kosaka Y, Felizardo TC, Medin JA, Tohda S, Schueler J, Fisch P, Keating A. Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells. Cytotherapy. 13: 753-64. PMID 21314241 DOI: 10.3109/14653249.2011.553595 |
0.354 |
|
| 2011 |
Siegers GM, Felizardo TC, Mathieson AM, Kosaka Y, Wang XH, Medin JA, Keating A. Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model. Plos One. 6: e16700. PMID 21304898 DOI: 10.1371/Journal.Pone.0016700 |
0.422 |
|
| 2011 |
Tolar J, Villeneuve P, Keating A. Mesenchymal stromal cells for graft-versus-host disease. Human Gene Therapy. 22: 257-62. PMID 21288086 DOI: 10.1089/Hum.2011.1104 |
0.427 |
|
| 2011 |
Kuruvilla J, Keating A, Crump M. How I treat relapsed and refractory Hodgkin lymphoma. Blood. 117: 4208-17. PMID 21263152 DOI: 10.1182/Blood-2010-09-288373 |
0.405 |
|
| 2011 |
Puig N, Pintilie M, Seshadri T, al-Farsi K, Franke N, Keating A, Kuruvilla J, Crump M. High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin's lymphoma. Bone Marrow Transplantation. 46: 1339-44. PMID 21243027 DOI: 10.1038/Bmt.2010.294 |
0.319 |
|
| 2011 |
Swift BE, Williams BA, Kosaka Y, Martínez-López J, Wang X, Keating A. Efficacy of NK-92 Against Human Multiple Myeloma in a NOD/SCID Gamma Null Mouse Model Blood. 118: 1854-1854. DOI: 10.1182/Blood.V118.21.1854.1854 |
0.383 |
|
| 2010 |
Yee KW, Keating A. Older patients with acute myeloid leukemia. Expert Review of Hematology. 3: 755-74. PMID 21091151 DOI: 10.1586/Ehm.10.68 |
0.33 |
|
| 2010 |
Prockop DJ, Brenner M, Fibbe WE, Horwitz E, Le Blanc K, Phinney DG, Simmons PJ, Sensebe L, Keating A. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy. 12: 576-8. PMID 20735162 DOI: 10.3109/14653249.2010.507330 |
0.377 |
|
| 2010 |
Williams DA, Keating A. Enhancing research in regenerative medicine. Blood. 116: 866-7. PMID 20705767 DOI: 10.1182/Blood-2010-05-282723 |
0.419 |
|
| 2010 |
Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, Kamble R, Copelan E, de Lima M, Gupta V, Keating A, Lazarus HM, Litzow MR, Marks DI, Maziarz RT, et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 3730-8. PMID 20625136 DOI: 10.1200/Jco.2010.28.8852 |
0.475 |
|
| 2010 |
Sun Z, Zhang Y, Brunt KR, Wu J, Li SH, Fazel S, Weisel RD, Keating A, Li RK. An adult uterine hemangioblast: evidence for extramedullary self-renewal and clonal bilineage potential. Blood. 116: 2932-41. PMID 20606165 DOI: 10.1182/Blood-2010-01-266882 |
0.41 |
|
| 2010 |
Tolar J, Le Blanc K, Keating A, Blazar BR. Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells (Dayton, Ohio). 28: 1446-55. PMID 20597105 DOI: 10.1002/Stem.459 |
0.452 |
|
| 2010 |
Puig N, Pintilie M, Seshadri T, Al-Farsi K, Nagy T, Franke N, Tsang R, Keating A, Crump M, Kuruvilla J. Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma. Haematologica. 95: 1496-502. PMID 20460643 DOI: 10.3324/Haematol.2009.019943 |
0.437 |
|
| 2010 |
Williams BA, Wang XH, Keating A. Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays. Cytotherapy. 12: 951-60. PMID 20230219 DOI: 10.3109/14653241003628167 |
0.374 |
|
| 2010 |
McClune BL, Weisdorf DJ, Pedersen TL, Tunes da Silva G, Tallman MS, Sierra J, Dipersio J, Keating A, Gale RP, George B, Gupta V, Hahn T, Isola L, Jagasia M, Lazarus H, et al. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1878-87. PMID 20212255 DOI: 10.1200/Jco.2009.25.4821 |
0.374 |
|
| 2010 |
Yuen DA, Connelly KA, Advani A, Liao C, Kuliszewski MA, Trogadis J, Thai K, Advani SL, Zhang Y, Kelly DJ, Leong-Poi H, Keating A, Marsden PA, Stewart DJ, Gilbert RE. Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism. Plos One. 5: e9543. PMID 20209052 DOI: 10.1371/Journal.Pone.0009543 |
0.363 |
|
| 2010 |
Litzow MR, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, Dipersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, et al. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood. 115: 1850-7. PMID 20032503 DOI: 10.1182/Blood-2009-10-249128 |
0.371 |
|
| 2010 |
Wang D, Stewart AK, Zhuang L, Zhu Y, Wang Y, Shi C, Keating A, Slutsky A, Zhang H, Wen XY. Enhanced adaptive immunity in mice lacking the immunoinhibitory adaptor Hacs1. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 947-56. PMID 19923443 DOI: 10.1096/Fj.09-140806 |
0.35 |
|
| 2010 |
Williams BA, Dief B, Wang X, Keating A. NK-92 Preferentially Targets Acute Myeloid Leukemia Stem Cells Blood. 116: 4300-4300. DOI: 10.1182/Blood.V116.21.4300.4300 |
0.31 |
|
| 2009 |
Wong AP, Keating A, Waddell TK. Airway regeneration: the role of the Clara cell secretory protein and the cells that express it. Cytotherapy. 11: 676-87. PMID 19878054 DOI: 10.3109/14653240903313974 |
0.353 |
|
| 2009 |
Vaughan W, Seshadri T, Bridges M, Keating A. The principles and overview of autologous hematopoietic stem cell transplantation. Cancer Treatment and Research. 144: 23-45. PMID 19779877 DOI: 10.1007/978-0-387-78580-6_2 |
0.456 |
|
| 2009 |
Sarugaser R, Hanoun L, Keating A, Stanford WL, Davies JE. Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy Plos One. 4. PMID 19652709 DOI: 10.1371/Journal.Pone.0006498 |
0.393 |
|
| 2009 |
Gómez-Aristizábal A, Keating A, Davies JE. Mesenchymal stromal cells as supportive cells for hepatocytes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1504-8. PMID 19584815 DOI: 10.1038/Mt.2009.158 |
0.446 |
|
| 2009 |
Gupta V, Tomblyn M, Pedersen TL, Atkins HL, Battiwalla M, Gress RE, Pollack MS, Storek J, Thompson JC, Tiberghien P, Young JA, Ribaud P, Horowitz MM, Keating A. Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 864-71. PMID 19539219 DOI: 10.1016/J.Bbmt.2009.03.023 |
0.409 |
|
| 2009 |
Seshadri T, Pintilie M, Kuruvilla J, Keating A, Tsang R, Zadeh S, Crump M. Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Leukemia & Lymphoma. 50: 380-6. PMID 19347727 DOI: 10.1080/10428190902756578 |
0.4 |
|
| 2009 |
Abrahamsson AE, Geron I, Gotlib J, Dao KH, Barroga CF, Newton IG, Giles FJ, Durocher J, Creusot RS, Karimi M, Jones C, Zehnder JL, Keating A, Negrin RS, Weissman IL, et al. Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. Proceedings of the National Academy of Sciences of the United States of America. 106: 3925-9. PMID 19237556 DOI: 10.1073/Pnas.0900189106 |
0.355 |
|
| 2009 |
Wong AP, Keating A, Lu WY, Duchesneau P, Wang X, Sacher A, Hu J, Waddell TK. Identification of a bone marrow-derived epithelial-like population capable of repopulating injured mouse airway epithelium. The Journal of Clinical Investigation. 119: 336-48. PMID 19164856 DOI: 10.1172/Jci36882 |
0.407 |
|
| 2009 |
Seshadri T, Keating A. Is there a role for autotransplants in AML in first remission? Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 17-20. PMID 19147071 DOI: 10.1016/J.Bbmt.2008.11.016 |
0.43 |
|
| 2009 |
Trinkaus MA, Lapinsky SE, Crump M, Keating A, Reece DE, Chen C, Hallett DC, Franke N, Winter A, Mikhael JR. Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit. Bone Marrow Transplantation. 43: 411-5. PMID 18936734 DOI: 10.1038/Bmt.2008.336 |
0.375 |
|
| 2009 |
Wannesson L, Wang L, Kuruvilla J, Nagy T, Saragosa R, Franke N, Keating A, Crump M. Peripheral Blood Stem Cell Harvests Performed Beyond the Initial Two Days of Apheresis May Not Contribute to Accelerate Granulocyte and Platelet Engraftment After Autologous Stem Cell Transplantation. Blood. 114: 3226-3226. DOI: 10.1182/Blood.V114.22.3226.3226 |
0.382 |
|
| 2009 |
Dhamko H, Siegers GM, Schüler J, Keating A. Superior Cytotoxicity of Clonal Versus Polyclonal Gamma Delta T Cells against Philadelphia Chromosome Positive and B-CLL Derived Leukemic Cells. Blood. 114: 3032-3032. DOI: 10.1182/Blood.V114.22.3032.3032 |
0.394 |
|
| 2009 |
Goda J, Massey C, Kuruvilla J, Gospodarowicz M, Wells W, Hodgson D, Sun A, Keating A, Crump M, Tsang R. 9224 Role of salvage radiation therapy in Hodgkin Lymphoma with relapsed or progressive disease despite autologous stem cell transplant European Journal of Cancer Supplements. 7: 567. DOI: 10.1016/S1359-6349(09)71915-9 |
0.432 |
|
| 2009 |
Tsang R, Goda J, Massey C, Kuruvilla J, Gospodarowicz M, Wells W, Hodgson D, Sun A, Crump M, Keating A. Hodgkin-Lymphoma with Relapsed or Progressive Disease after Autologous Stem Cell Transplantation: Efficacy of Salvage Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 75: S64. DOI: 10.1016/J.Ijrobp.2009.07.164 |
0.347 |
|
| 2008 |
Rose RA, Keating A, Backx PH. Do mesenchymal stromal cells transdifferentiate into functional cardiomyocytes? Circulation Research. 103: e120. PMID 18948624 DOI: 10.1161/Circresaha.108.186908 |
0.326 |
|
| 2008 |
Seshadri T, Stakiw J, Pintilie M, Keating A, Crump M, Kuruvilla J. Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy. Hematology (Amsterdam, Netherlands). 13: 261-6. PMID 18854087 DOI: 10.1179/102453308X343527 |
0.383 |
|
| 2008 |
Jones KB, Seshadri T, Krantz R, Keating A, Ferguson PC. Cell-based therapies for osteonecrosis of the femoral head. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 1081-7. PMID 18804037 DOI: 10.1016/J.Bbmt.2008.06.017 |
0.431 |
|
| 2008 |
Williams BA, Keating A. Cell therapy for age-related disorders: myocardial infarction and stroke--a mini-review. Gerontology. 54: 300-11. PMID 18797160 DOI: 10.1159/000156223 |
0.361 |
|
| 2008 |
Seshadri T, Al-Farsi K, Stakiw J, Ma C, Saragosa R, Franke N, Keating A, Crump M, Kuruvilla J. G-CSF-stimulated BM progenitor cells supplement suboptimal peripheral blood hematopoietic progenitor cell collections for auto transplantation. Bone Marrow Transplantation. 42: 733-7. PMID 18711349 DOI: 10.1038/Bmt.2008.249 |
0.444 |
|
| 2008 |
Rose RA, Jiang H, Wang X, Helke S, Tsoporis JN, Gong N, Keating SC, Parker TG, Backx PH, Keating A. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells (Dayton, Ohio). 26: 2884-92. PMID 18687994 DOI: 10.1634/Stemcells.2008-0329 |
0.385 |
|
| 2008 |
Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP, Halter J, Keating A, Marks DI, McCarthy PL, Olavarria E, et al. Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. Blood. 112: 3500-7. PMID 18664621 DOI: 10.1182/Blood-2008-02-141689 |
0.33 |
|
| 2008 |
Smith SM, van Besien K, Carreras J, Bashey A, Cairo MS, Freytes CO, Gale RP, Hale GA, Hayes-Lattin B, Holmberg LA, Keating A, Maziarz RT, McCarthy PL, Navarro WH, Pavlovsky S, et al. Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 904-12. PMID 18640574 DOI: 10.1016/J.Bbmt.2008.05.021 |
0.416 |
|
| 2008 |
Kuruvilla J, Pintilie M, Tsang R, Nagy T, Keating A, Crump M. Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma. Leukemia & Lymphoma. 49: 1329-36. PMID 18604722 DOI: 10.1080/10428190802108870 |
0.439 |
|
| 2008 |
Parr AM, Kulbatski I, Zahir T, Wang X, Yue C, Keating A, Tator CH. Transplanted adult spinal cord-derived neural stem/progenitor cells promote early functional recovery after rat spinal cord injury. Neuroscience. 155: 760-70. PMID 18588947 DOI: 10.1016/J.Neuroscience.2008.05.042 |
0.378 |
|
| 2008 |
Marks DI, Pérez WS, He W, Zhang MJ, Bishop MR, Bolwell BJ, Bredeson CN, Copelan EA, Gale RP, Gupta V, Hale GA, Isola LM, Jakubowski AA, Keating A, Klumpp TR, et al. Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood. 112: 426-34. PMID 18398065 DOI: 10.1182/Blood-2007-12-128918 |
0.414 |
|
| 2008 |
Seshadri T, Pintilie M, Keating A, Crump M, Kuruvilla J. The relationship between absolute lymphocyte count with PFS in patients with Hodgkin's lymphoma undergoing autologous hematopoietic cell transplant. Bone Marrow Transplantation. 42: 29-34. PMID 18332908 DOI: 10.1038/Bmt.2008.41 |
0.417 |
|
| 2008 |
Parr AM, Kulbatski I, Wang XH, Keating A, Tator CH. Fate of transplanted adult neural stem/progenitor cells and bone marrow-derived mesenchymal stromal cells in the injured adult rat spinal cord and impact on functional recovery. Surgical Neurology. 70: 600-7; discussion 60. PMID 18291482 DOI: 10.1016/J.Surneu.2007.09.043 |
0.334 |
|
| 2008 |
Seshadri T, Kuruvilla J, Crump M, Keating A. Salvage therapy for relapsed/refractory diffuse large B cell lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 259-67. PMID 18275892 DOI: 10.1016/J.Bbmt.2007.11.013 |
0.376 |
|
| 2008 |
Oliansky DM, Appelbaum F, Cassileth PA, Keating A, Kerr J, Nieto Y, Stewart S, Stone RM, Tallman MS, McCarthy PL, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 137-80. PMID 18215777 DOI: 10.1016/J.Bbmt.2007.11.002 |
0.397 |
|
| 2008 |
Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn JY, Lazarus HM, Litzow MR, Marks DI, Wiernik PH, McCarthy PL, Russell JA, Miller CB, Sierra J, Milone G, Keating A, et al. Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. Bone Marrow Transplantation. 41: 635-42. PMID 18084335 DOI: 10.1038/Sj.Bmt.1705952 |
0.421 |
|
| 2008 |
Fazel SS, Chen L, Angoulvant D, Li SH, Weisel RD, Keating A, Li RK. Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 930-40. PMID 17967925 DOI: 10.1096/Fj.07-8636Com |
0.345 |
|
| 2008 |
Siegers GM, Al-Beirouti BM, Mathieson AM, Felizardo TC, Helke S, Medin JA, Keating A. Gamma Delta T Cells (GDTCs) to Eliminate Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia (CML) : A Pre-Clinical Model Blood. 112: 574-574. DOI: 10.1182/Blood.V112.11.574.574 |
0.362 |
|
| 2008 |
Telio D, Ma C, Tsang R, Keating A, Crump M, Kuruvilla J. Outcomes of Second-Line Chemotherapy and Autologous Stem Cell Transplantation for Primary Refractory Diffuse Large B Cell Lymphoma Blood. 112: 4445-4445. DOI: 10.1182/Blood.V112.11.4445.4445 |
0.349 |
|
| 2008 |
McClune B, Weisdorf DJ, DiPersio JF, Keating A, Pedersen TL, da Silva GT, Sierra J, Tallman MS, Giralt SA. Non-Myeloablative Hematopoietic Stem Cell Transplantation in Older Patients with AML and MDS: Results from the Center for International Blood and Marrow Transplant Research (CIBMTR) Blood. 112: 346-346. DOI: 10.1182/Blood.V112.11.346.346 |
0.321 |
|
| 2008 |
Kuruvilla J, Taylor D, Wang L, Blattler C, Keating A, Crump M. Phase II Trial of Lenalidomide in Patients with Relapsed or Refractory Hodgkin Lymphoma Blood. 112: 3052-3052. DOI: 10.1182/Blood.V112.11.3052.3052 |
0.31 |
|
| 2008 |
Yannarelli G, Jiang H, Montanari S, Helke S, Wang X, Keating A. Oct4 Expression and Mesenchymal Stromal Cell Plasticity Blood. 112: 2899-2899. DOI: 10.1182/Blood.V112.11.2899.2899 |
0.721 |
|
| 2008 |
Hu CD, Kosaka Y, Keating A. Human Mesenchymal Stromal Cells (MSCs) Suppress Cytotoxicity of Natural Killer (NK) Cell Lines and Can Be Targets for NK-Mediated Cytolysis Blood. 112: 2576-2576. DOI: 10.1182/Blood.V112.11.2576.2576 |
0.322 |
|
| 2008 |
Seshadri T, Massey C, Puig N, Keating A, Crump M, Kuruvilla J. Outcome of Transplant-Eligible Patients with Hodgkin Lymphoma with An Inadequate Response to Second Line Chemotherapy with Gemcitabine, Dexamethasone, Cisplatin (GDP). Blood. 112: 2179-2179. DOI: 10.1182/Blood.V112.11.2179.2179 |
0.374 |
|
| 2008 |
Tsoporis JN, Jiang H, Wang X, Desjardins J, Pourdjabbar A, Keating A, Parker TG. Infused marrow stromal cells lodged in damaged myocardium exhibit a phenotype with stromal and cardiomyocyte markers Journal of Molecular and Cellular Cardiology. 44: 734-735. DOI: 10.1016/J.Yjmcc.2008.02.057 |
0.397 |
|
| 2008 |
Al-Farsi K, Nagy T, Keating A, Crump M, Kuruvilla J. 99: Predictors of Outcome of Mantle Cell Lymphoma in Patients with Progressive Disease following Autologous Stem Cell Transplantation (ASCT) Biology of Blood and Marrow Transplantation. 14: 38-39. DOI: 10.1016/J.Bbmt.2007.12.108 |
0.47 |
|
| 2008 |
Al-Farsi K, Zadeh S, Nagy T, Franke N, Keating A, Crump M, Kuruvilla J. 86: Long-Term Follow-Up of Autologous Stem Cell Transplant (ASCT) in Patients with Mantle Cell Lymphoma (MCL) Biology of Blood and Marrow Transplantation. 14: 34. DOI: 10.1016/J.Bbmt.2007.12.095 |
0.478 |
|
| 2007 |
Wu J, Sun Z, Sun HS, Wu J, Weisel RD, Keating A, Li ZH, Feng ZP, Li RK. Intravenously Administered Bone Marrow Cells Migrate to Damaged Brain Tissue and Improve Neural Function in Ischemic Rats. Cell Transplantation. 16: 993-1005. PMID 28866928 DOI: 10.3727/000000007783472435 |
0.349 |
|
| 2007 |
Neschadim A, McCart JA, Keating A, Medin JA. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 1407-16. PMID 18022569 DOI: 10.1016/J.Bbmt.2007.09.014 |
0.399 |
|
| 2007 |
Bastianutto C, Mian A, Symes J, Mocanu J, Alajez N, Sleep G, Shi W, Keating A, Crump M, Gospodarowicz M, Medin J, Minden M, Liu FF. Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow. Cancer Research. 67: 10112-6. PMID 17974951 DOI: 10.1158/0008-5472.Can-07-2192 |
0.374 |
|
| 2007 |
Parr AM, Tator CH, Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury Bone Marrow Transplantation. 40: 609-619. PMID 17603514 DOI: 10.1038/Sj.Bmt.1705757 |
0.333 |
|
| 2007 |
Tallman MS, Dewald GW, Gandham S, Logan BR, Keating A, Lazarus HM, Litzow MR, Mehta J, Pedersen T, Pérez WS, Rowe JM, Wetzler M, Weisdorf DJ. Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. Blood. 110: 409-17. PMID 17374741 DOI: 10.1182/Blood-2006-10-043299 |
0.38 |
|
| 2007 |
Stakiw J, Kuruvilla J, Al-Farsi K, Zadeh S, Nagy T, Keating A, Crump M. Outcome following multiple lines of salvage chemotherapy prior to autologous stem cell transplant for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) Journal of Clinical Oncology. 25: 8120-8120. DOI: 10.1200/Jco.2007.25.18_Suppl.8120 |
0.362 |
|
| 2007 |
Dhani NC, Roberts T, Pintilie M, Kuruvilla J, Franke N, Nagy T, Tsang R, Keating A, Crump M. Late treatment mortality and secondary cancers after autologous stem cell transplant for relapsed or refractory Hodgkin lymphoma (HL) Journal of Clinical Oncology. 25: 8016-8016. DOI: 10.1200/Jco.2007.25.18_Suppl.8016 |
0.368 |
|
| 2007 |
Abrahamsson A, Geron I, Gotlib J, Dao K, Giles F, Newton I, Kavalerchik E, Durocher J, Creusot R, Karimi M, Jones C, Zehnder J, Keating A, Negrin R, Weissman IL, et al. Missplicing of Glycogen Synthase Kinase 3β: A Potential Mechanism of Blast Crisis Chronic Myeloid Leukemia Stem Cell Generation. Blood. 110: 775-775. DOI: 10.1182/Blood.V110.11.775.775 |
0.361 |
|
| 2007 |
Litzow M, Pérez WS, Tarima S, Keating A, Sierra J, Tallman M, Weisdorf D. Allogeneic Stem Cell Transplantation (AlloSCT) for the Treatment of Therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML): Results from the Center for International Blood and Marrow Transplant Research (CIBMTR). Blood. 110: 3057-3057. DOI: 10.1182/Blood.V110.11.3057.3057 |
0.431 |
|
| 2007 |
Marks DI, Pérez WS, He V, Zhang M, Keating A, Tallman M, Sierra J, Weisdorf D. Unrelated Donor (URD) Hematopoietic Stem Cell Transplantation (HCT) for Adults with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia (ALL) in First Complete Remission (CR1): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis. Blood. 110: 3055-3055. DOI: 10.1182/Blood.V110.11.3055.3055 |
0.421 |
|
| 2007 |
Seshadri T, Al-Farsi K, Stakiw J, Ma C, Saragosa R, Keating A, Crump M, Kuruvilla J. Short and Long Term Efficacy of Autologous Bone Marrow Cells To Support Intensive Chemotherapy in Patients Failing Peripheral Blood Stem Cell Mobilization. Blood. 110: 2999-2999. DOI: 10.1182/Blood.V110.11.2999.2999 |
0.435 |
|
| 2007 |
Rose RA, Jiang H, Wang XH, Helke S, Tsoporis JN, Gong N, Keating SC, Parker TG, Bacx P, Keating A. Mesenchymal Stromal Cells (MSCs) Acquire Cardiac-Specific Markers but Do Not Become Functional Cardiomyocytes and Retain the Stromal Phenotype. Blood. 110: 1920-1920. DOI: 10.1182/Blood.V110.11.1920.1920 |
0.375 |
|
| 2007 |
Dhani N, Roberts T, Pintilie M, Kuruvilla J, Franke N, Nagy T, Tsang R, Keating A, Crump M. Risk of Acute Leukemia Post-Autologous Stem Cell Tranplant (ASCT) for Hodgkin’s Lymphoma (HL) Depends on Choice of Salvage Chemotherapy and Use of Radiation. Blood. 110: 1674-1674. DOI: 10.1182/Blood.V110.11.1674.1674 |
0.362 |
|
| 2007 |
Seshadri T, Pintilie M, Tsang R, Kuruvilla J, Zadeh S, Keating A, Crump M. Second Cancers after Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma (NHL). Blood. 110: 1673-1673. DOI: 10.1182/Blood.V110.11.1673.1673 |
0.394 |
|
| 2007 |
Keating A. Prospective Clinical Trials in BMT Come of Age in the US: The Blood and Marrow Transplant Clinical Trials Network Biology of Blood and Marrow Transplantation. 13: 255-256. DOI: 10.1016/J.Bbmt.2007.01.068 |
0.382 |
|
| 2006 |
Wannesson L, Panzarella T, Mikhael J, Keating A. Feasibility and safety of autotransplants with noncryopreserved marrow or peripheral blood stem cells: a systematic review Annals of Oncology. 18: 623-632. PMID 17355952 DOI: 10.1093/Annonc/Mdm069 |
0.435 |
|
| 2006 |
Wingard JR, Leahigh AK, Confer D, Edwards J, Billups RL, van den Brink M, Keating A. Preparing for the unthinkable: emergency preparedness for the hematopoietic cell transplant program. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 1229-38. PMID 17085317 DOI: 10.1016/J.Bbmt.2006.08.001 |
0.349 |
|
| 2006 |
Keating A. Mesenchymal stromal cells. Current Opinion in Hematology. 13: 419-25. PMID 17053453 DOI: 10.1097/01.Moh.0000245697.54887.6F |
0.407 |
|
| 2006 |
Aswald JM, Wang XH, Aswald S, Lutynski A, Minden MD, Messner HA, Keating A. Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy? Cytometry. Part B, Clinical Cytometry. 70: 379-90. PMID 16977635 DOI: 10.1002/Cyto.B.20115 |
0.359 |
|
| 2006 |
Dominici M, Blanc KL, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy. 8: 315-317. PMID 16923606 DOI: 10.1080/14653240600855905 |
0.352 |
|
| 2006 |
Suck G, Branch DR, Aravena P, Mathieson M, Helke S, Keating A. Constitutively polarized granules prime KHYG-1 NK cells. International Immunology. 18: 1347-54. PMID 16849396 DOI: 10.1093/Intimm/Dxl071 |
0.321 |
|
| 2006 |
Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. The Journal of Clinical Investigation. 116: 1865-77. PMID 16823487 DOI: 10.1172/Jci27019 |
0.405 |
|
| 2006 |
Suck G, Branch DR, Keating A. Irradiated KHYG-1 retains cytotoxicity: potential for adoptive immunotherapy with a natural killer cell line. International Journal of Radiation Biology. 82: 355-361. PMID 16782653 DOI: 10.1080/09553000600649653 |
0.344 |
|
| 2006 |
Marks DI, Forman SJ, Blume KG, Pérez WS, Weisdorf DJ, Keating A, Gale RP, Cairo MS, Copelan EA, Horan JT, Lazarus HM, Litzow MR, McCarthy PL, Schultz KR, Smith DD, et al. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 438-53. PMID 16545728 DOI: 10.1016/J.Bbmt.2005.12.029 |
0.316 |
|
| 2006 |
Kuruvilla J, Song K, Mollee P, Panzarella T, McCrae J, Nagy T, Crump M, Keating A. A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma. Hematology (Amsterdam, Netherlands). 11: 25-9. PMID 16522545 DOI: 10.1080/10245330500276592 |
0.39 |
|
| 2006 |
Lazarus HM, Pérez WS, Klein JP, Kollman C, Bate-Boyle B, Bredeson CN, Gale RP, Geller RB, Keating A, Litzow MR, Marks DI, Miller CB, Douglas Rizzo J, Spitzer TR, Weisdorf DJ, et al. Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research. British Journal of Haematology. 132: 755-69. PMID 16487177 DOI: 10.1111/J.1365-2141.2005.05947.X |
0.407 |
|
| 2006 |
Kuruvilla J, Nagy T, Pintilie M, Tsang R, Keating A, Crump M. Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma. Cancer. 106: 353-60. PMID 16329112 DOI: 10.1002/Cncr.21587 |
0.404 |
|
| 2006 |
Wu G, Kuruvilla J, Nagy T, Keating A, Crump M. Outcome of salvage therapy for relapsed or refractory peripheral T-cell lymphoma (PTCL), anaplastic large cell lymphoma (ALCL), and diffuse large B-cell lymphoma (DLBCL) Journal of Clinical Oncology. 24: 6544-6544. DOI: 10.1200/Jco.2006.24.18_Suppl.6544 |
0.408 |
|
| 2006 |
Gupta V, Tomblyn M, Pederson T, Thompson J, Gress R, Storek J, Burik Jv, Horowitz M, Keating A. Allogeneic Hematopoietic Stem Cell Transplantation in HIV-Positive Patients with Malignant and Non-Malignant Disorders: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR). Blood. 108: 5353-5353. DOI: 10.1182/Blood.V108.11.5353.5353 |
0.412 |
|
| 2006 |
Kuruvilla J, Gupta V, Zaretsky Y, Zadeh S, Nagy T, Keating A, Crump M. Inferior Progression-Free Survival after Autotransplant for Relapsed or Refractory Aggressive Non-Hodgkin’s Lymphoma in Patients > 60 Versus ≤ 60 Years of Age. Blood. 108: 3068-3068. DOI: 10.1182/Blood.V108.11.3068.3068 |
0.36 |
|
| 2006 |
Kuo KH, Callum J, Brandwein J, Crump M, Curtis JE, Gupta V, Lipton JH, Pantalony D, Schimmer A, Schuh A, Sher G, Sutton DM, Yee KW, Keating A, Minden MD, et al. Management of Hyperleukocytosis in Acute Myelogenous Leukemia Using Hydroxyurea Rather Than Leukopheresis. Blood. 108: 2007-2007. DOI: 10.1182/Blood.V108.11.2007.2007 |
0.309 |
|
| 2006 |
Kuruvilla J, Chen C, Pintilie M, Nagy T, Keating A, Crump M. Outcomes of salvage chemotherapy and autologous transplantation for large cell transformation of follicular lymphoma—A comparison of outcomes with relapsed/refractory diffuse large B cell lymphoma Biology of Blood and Marrow Transplantation. 12: 120. DOI: 10.1016/J.Bbmt.2005.11.367 |
0.382 |
|
| 2005 |
Seebach JD, Stussi G, Passweg JR, Loberiza FR, Gajewski JL, Keating A, Goerner M, Rowlings PA, Tiberghien P, Elfenbein GJ, Gale RP, van Rood JJ, Reddy V, Gluckman E, Bolwell BJ, et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 1006-13. PMID 16338623 DOI: 10.1016/J.Bbmt.2005.07.015 |
0.43 |
|
| 2005 |
Horwitz EM, Blanc KL, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement Cytotherapy. 7: 393-395. PMID 16236628 DOI: 10.1080/14653240500319234 |
0.429 |
|
| 2005 |
Suck G, Branch DR, Smyth MJ, Miller RG, Vergidis J, Fahim S, Keating A. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity. Experimental Hematology. 33: 1160-71. PMID 16219538 DOI: 10.1016/J.Exphem.2005.06.024 |
0.317 |
|
| 2005 |
Baker KS, Loberiza FR, Yu H, Cairo MS, Bolwell BJ, Bujan-Boza WA, Camitta BM, Garcia JJ, Ho WG, Liesveld JL, Maharaj D, Marks DI, Schultz KR, Wiernik P, Zander AR, ... ... Keating A, et al. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7032-42. PMID 16145067 DOI: 10.1200/Jco.2005.01.7269 |
0.435 |
|
| 2005 |
Bubnic SJ, Nagy A, Keating A. Donor hematopoietic cells from transgenic mice that express GFP are immunogenic in immunocompetent recipients. Hematology (Amsterdam, Netherlands). 10: 289-95. PMID 16085541 DOI: 10.1080/10245330500093468 |
0.778 |
|
| 2005 |
Mothe AJ, Kulbatski I, van Bendegem RL, Lee L, Kobayashi E, Keating A, Tator CH. Analysis of green fluorescent protein expression in transgenic rats for tracking transplanted neural stem/progenitor cells. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 53: 1215-26. PMID 15983120 DOI: 10.1369/Jhc.5A6639.2005 |
0.391 |
|
| 2005 |
Keating A. Bone marrow cells for cardiac repair. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 2-6. PMID 15682165 DOI: 10.1016/J.Bbmt.2004.11.002 |
0.348 |
|
| 2005 |
Jamieson C, Karimi M, Creusot R, Negrin R, Gotlib J, Chao M, Jones C, Keating A, Fathman CG, Zehnder J, Weissman IL. Bioluminescent Imaging of Human Leukemic Stem Cell Engraftment. Blood. 106: 696-696. DOI: 10.1182/Blood.V106.11.696.696 |
0.455 |
|
| 2005 |
Kuruvilla J, Nagy T, Pintilie M, Keating A, Crump M. Outcomes of Salvage Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B Cell Lymphoma (PMLCL) Are Inferior to Diffuse Large B Cell Lymphoma (DLBCL). Blood. 106: 2085-2085. DOI: 10.1182/Blood.V106.11.2085.2085 |
0.348 |
|
| 2004 |
Song KW, Rifkind J, Al-Beirouti B, Yee K, McCrae J, Messner HA, Keating A, Lipton JH. Subdural hematomas during CML therapy with imatinib mesylate. Leukemia & Lymphoma. 45: 1633-6. PMID 15370217 DOI: 10.1080/10428190310001615666 |
0.313 |
|
| 2004 |
Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating A, Sawyers CL, Weissman IL. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. The New England Journal of Medicine. 351: 657-67. PMID 15306667 DOI: 10.1056/Nejmoa040258 |
0.368 |
|
| 2004 |
Berkahn L, Keating A. Hematopoiesis in the elderly. Hematology (Amsterdam, Netherlands). 9: 159-63. PMID 15204096 DOI: 10.1080/10245330410001701468 |
0.443 |
|
| 2004 |
Mollee P, Gupta V, Song K, Reddy V, Califaretti N, Tsang R, Crump M, Keating A. Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia. Bone Marrow Transplantation. 33: 1201-8. PMID 15094745 DOI: 10.1038/Sj.Bmt.1704506 |
0.428 |
|
| 2004 |
Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, ... ... Keating A, et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood. 104: 579-85. PMID 15039286 DOI: 10.1182/Blood-2004-01-0338 |
0.391 |
|
| 2004 |
Gupta V, Lazarus HM, Keating A. Myeloablative conditioning regimens for AML allografts: 30 years later. Bone Marrow Transplantation. 32: 969-78. PMID 14595384 DOI: 10.1038/Sj.Bmt.1704285 |
0.351 |
|
| 2004 |
Kuruvilla J, Nagy T, Pintilie M, Keating A, Crump M. GDP (Gemcitabine, Dexamethasone, Cisplatin) Salvage Therapy Results in Superior Progression Free Survival Compared to Mini-Beam Prior to Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin’s Lymphoma. Blood. 104: 905-905. DOI: 10.1182/Blood.V104.11.905.905 |
0.357 |
|
| 2004 |
Suck G, Branch DR, Vergidis J, Fahim S, Keating A. Identifying Mechanisms of Enhanced NK Cell Cytotoxicity Using Permanent NK Cell Lines. Blood. 104: 3842-3842. DOI: 10.1182/Blood.V104.11.3842.3842 |
0.343 |
|
| 2004 |
Chen CI, Nagy T, Yi Q, Keating A, Crump M. A Phase II Study of Peripheral Blood Stem Cell (PBSC) Mobilization Using Stem Cell Factor (SCF), Filgrastin (G-CSF), and Cyclophosphamide (CY) in Patients at High Risk for Mobilization Failure. Blood. 104: 2883-2883. DOI: 10.1182/Blood.V104.11.2883.2883 |
0.37 |
|
| 2004 |
Aswald JM, Wang X, Aswald S, Benoit LA, Minden M, Messner HA, Keating A. Autologous Gamma-Delta T (GD-T) Cells in Acute Myeloid Leukemia (AML): Potential Immune Effector Cells for Minimal Disease?. Blood. 104: 2538-2538. DOI: 10.1182/Blood.V104.11.2538.2538 |
0.374 |
|
| 2004 |
Vergidis J, Suck G, Wang X, Zandstra PW, Keating A. Culture Conditions for Generating Human Bone Marrow Stromal Cells Influence Cell Immunophenotype and In Vivo Biodistribution in Immune Deficient Mice. Blood. 104: 2334-2334. DOI: 10.1182/Blood.V104.11.2334.2334 |
0.442 |
|
| 2003 |
Reece DE, Bredeson C, Pérez WS, Jagannath S, Zhang MJ, Ballen KK, Elfenbein GJ, Freytes CO, Gale RP, Gertz MA, Gibson J, Giralt SA, Keating A, Kyle RA, Maharaj D, et al. Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age. Bone Marrow Transplantation. 32: 1135-43. PMID 14647267 DOI: 10.1038/Sj.Bmt.1704288 |
0.432 |
|
| 2003 |
Yee KW, Keating A. Advances in targeted therapy for chronic myeloid leukemia. Expert Review of Anticancer Therapy. 3: 295-310. PMID 12820774 DOI: 10.1586/14737140.3.3.295 |
0.318 |
|
| 2003 |
Song KW, Mollee P, Keating A, Crump M. Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. British Journal of Haematology. 120: 978-85. PMID 12648067 DOI: 10.1046/J.1365-2141.2003.04203.X |
0.444 |
|
| 2003 |
Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, et al. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood. 101: 2015-23. PMID 12393427 DOI: 10.1182/Blood-2002-04-1261 |
0.397 |
|
| 2002 |
Bubnic SJ, Wang XH, Clark BR, Keating A. W/Wv marrow stromal cells engraft and enhance early erythropoietic progenitors in unconditioned Sl/Sld murine recipients. Bone Marrow Transplantation. 30: 867-72. PMID 12476278 DOI: 10.1038/sj.bmt.1703761 |
0.804 |
|
| 2002 |
Litzow MR, Pérez WS, Klein JP, Bolwell BJ, Camitta B, Copelan EA, Gale RP, Giralt SA, Keating A, Lazarus HM, Marks DI, McCarthy PL, Miller CB, Milone G, Prentice HG, et al. Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. British Journal of Haematology. 119: 1115-24. PMID 12472596 DOI: 10.1046/J.1365-2141.2002.03973.X |
0.424 |
|
| 2002 |
Mollee P, Pereira D, Nagy T, Song K, Saragosa R, Keating A, Crump M. Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma. Bone Marrow Transplantation. 30: 273-8. PMID 12209348 DOI: 10.1038/Sj.Bmt.1703653 |
0.441 |
|
| 2002 |
Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, Canals C, Boogaerts MA, Goldman J, Champlin RE, Keating A, et al. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood. 100: 1997-2004. PMID 12200358 DOI: 10.1182/Blood.V100.6.1997.H81802001997_1997_2004 |
0.441 |
|
| 2002 |
Bubnic SJ, Keating A. Donor stem cells home to marrow efficiently and contribute to short- and long-term hematopoiesis after low-cell-dose unconditioned bone marrow transplantation. Experimental Hematology. 30: 606-11. PMID 12063028 DOI: 10.1016/S0301-472X(02)00800-7 |
0.794 |
|
| 2002 |
Schimmer AD, Dranitsaris G, Ali V, Falconer M, Keating A. The autologous blood and marrow transplant long-term follow-up clinic: A model of care for following and treating survivors of autotransplant Supportive Care in Cancer. 10: 247-252. PMID 11904790 DOI: 10.1007/S00520-001-0316-1 |
0.329 |
|
| 2001 |
Miller CB, Rowlings PA, Zhang MJ, Jones RJ, Piantadosi S, Keating A, Armitage JO, Calderwood S, Harris RE, Klein JP, Lazarus HM, Linker CA, Sobocinski KA, Weisdorf D, Horowitz MM. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. Experimental Hematology. 29: 1336-46. PMID 11698130 DOI: 10.1016/S0301-472X(01)00732-9 |
0.423 |
|
| 2001 |
Schimmer AD, Mah K, Bordeleau L, Cheung A, Ali V, Falconer M, Trus M, Keating A. Decreased bone mineral density is common after autologous blood or marrow transplantation. Bone Marrow Transplantation. 28: 387-91. PMID 11571512 DOI: 10.1038/Sj.Bmt.1703149 |
0.309 |
|
| 2001 |
Schimmer AD, Ali V, Stewart AK, Imrie K, Keating A. Male sexual function after autologous blood or marrow transplantation Biology of Blood and Marrow Transplantation. 7: 279-283. PMID 11400950 DOI: 10.1053/Bbmt.2001.V7.Pm11400950 |
0.308 |
|
| 2001 |
Chen CI, Crump M, Tsang R, Stewart AK, Keating A. Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma. British Journal of Haematology. 113: 202-8. PMID 11328303 DOI: 10.1046/J.1365-2141.2001.02705.X |
0.404 |
|
| 2001 |
Chen CI, Abraham R, Tsang R, Crump M, Keating A, Stewart AK. Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes. Bone Marrow Transplantation. 27: 177-82. PMID 11281387 DOI: 10.1038/sj.bmt.1702771 |
0.31 |
|
| 2001 |
Horwitz E, Prockop D, Keating A, Butcher B, Brenner M. Meeting Report: Mesenchymal and nonhematopoietic stem cells: recent progress and current controversies Cytotherapy. 3: 391-392. DOI: 10.1080/146532401753277698 |
0.325 |
|
| 2000 |
Curtis JE, Hao Y, Messner HA, Lipton JH, Lowsky R, Quirt IC, Sturgeon JF, Zanke B, Keating A, Minden MD. Acute Myeloblastic Leukemia: Management with High-Dose Cytosine Arabinoside, Daunorubicin and Marrow Transplantation; Malignancy; Current Clinical Practice. Hematology (Amsterdam, Netherlands). 5: 177-187. PMID 11399613 DOI: 10.1080/10245332.2000.11746507 |
0.357 |
|
| 2000 |
Charbord P, Rémy-Martin JP, Tamayo E, Bernard G, Keating A, Péault B. Analysis of the Microenvironment Necessary for Engraftment: Role of the Vascular Smooth Muscle-like Stromal Cells Journal of Hematotherapy & Stem Cell Research. 9: 935-943. PMID 11177608 DOI: 10.1089/152581600750062390 |
0.383 |
|
| 2000 |
Schimmer AD, Jamal S, Messner H, Keating A, Meharchand J, Huebsch L, Walker I, Benger A, Gluck S, Smith A. Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy. Ontario BMT Network, Canada. Bone Marrow Transplantation. 26: 859-64. PMID 11081385 DOI: 10.1038/Sj.Bmt.1702625 |
0.42 |
|
| 2000 |
Jiang Z, Liang P, Leng R, Guo Z, Liu Y, Liu X, Bubnic S, Keating A, Murray D, Goss P, Zacksenhaus E. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis. Developmental Biology. 227: 8-41. PMID 11076674 DOI: 10.1006/Dbio.2000.9892 |
0.733 |
|
| 2000 |
Saba N, Abraham R, Keating A. Overview of autologous stem cell transplantation. Critical Reviews in Oncology Hematology. 36: 27-48. PMID 10996521 DOI: 10.1016/S1040-8428(00)00087-1 |
0.485 |
|
| 2000 |
Patnaik A, MacKinnon J, Goss P, Nagy T, Stewart K, Keating A, Crump M. Phase I/II trial of cyclophosphamide, mitoxantrone, and escalated doses of carboplatin supported by peripheral-blood stem cells in women with metastatic breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 2363-8. PMID 10856095 DOI: 10.1200/Jco.2000.18.12.2363 |
0.325 |
|
| 2000 |
Schimmer AD, Minden MD, Keating A. Osteoporosis after Blood and Marrow Transplantation: Clinical Aspects Biology of Blood and Marrow Transplantation. 6: 175-181. PMID 10816025 DOI: 10.1016/S1083-8791(00)70040-1 |
0.322 |
|
| 2000 |
Davies SM, Ramsay NK, Klein JP, Weisdorf DJ, Bolwell B, Cahn JY, Camitta BM, Gale RP, Giralt S, Heilmann C, Henslee-Downey PJ, Herzig RH, Hutchinson R, Keating A, Lazarus HM, et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 340-7. PMID 10637248 DOI: 10.1200/Jco.2000.18.2.340 |
0.368 |
|
| 2000 |
Abraham R, Chen C, Tsang R, Simpson D, Murray C, Davidson M, Meharchand J, Sutton DM, Crump RM, Keating A, Stewart AK. Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma. Bone Marrow Transplantation. 24: 1291-7. PMID 10627637 DOI: 10.1038/Sj.Bmt.1702060 |
0.437 |
|
| 1999 |
Saba N, Sutton D, Ross H, Siu S, Crump R, Keating A, Stewart A. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplantation. 24: 853-5. PMID 10516696 DOI: 10.1038/Sj.Bmt.1702005 |
0.427 |
|
| 1999 |
Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase Leukemia Research. 23: 817-826. PMID 10475621 DOI: 10.1016/S0145-2126(99)00097-1 |
0.391 |
|
| 1999 |
Tsang RW, Gospodarowicz MK, Sutcliffe SB, Crump M, Keating A. Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease. PMH Lymphoma Group, and the Toronto Autologous BMT Group. European Journal of Cancer (Oxford, England : 1990). 35: 73-8. PMID 10211091 DOI: 10.1016/S0959-8049(98)00304-9 |
0.364 |
|
| 1999 |
LaCasse EC, Bray MR, Patterson B, Lim W-, Perampalam S, Radvanyi LG, Keating A, Stewart AK, Buckstein R, Sandhu JS, Miller N, Banerjee D, Singh D, Belch AR, Pilarski LM, et al. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation. Blood. 94: 2901-2910. DOI: 10.1182/Blood.V94.8.2901.420K36_2901_2910 |
0.433 |
|
| 1998 |
Lichty BD, Keating A, Callum J, Yee K, Croxford R, Corpus G, Nwachukwu B, Kim P, Guo J, Kamel-Reid S. Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia British Journal of Haematology. 103: 711-715. PMID 9858221 DOI: 10.1046/J.1365-2141.1998.01033.X |
0.319 |
|
| 1998 |
Schimmer AD, Stewart AK, Keating A, MacKinnon J, Crump M, Sutton DM, Shepherd FA, Meharchand J. Safety of therapeutic anticoagulation in patients with multiple myeloma receiving autologous stem cell transplantation. Bone Marrow Transplantation. 22: 491-4. PMID 9733273 DOI: 10.1038/Sj.Bmt.1701363 |
0.369 |
|
| 1998 |
Schimmer AD, Quatermain M, Imrie K, Ali V, McCrae J, Stewart AK, Crump M, Derzko C, Keating A. Ovarian function after autologous bone marrow transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 2359-63. PMID 9667251 DOI: 10.1200/Jco.1998.16.7.2359 |
0.371 |
|
| 1998 |
Keating A, Berkahn L, Filshie R. A Phase I study of the transplantation of genetically marked autologous bone marrow stromal cells. Human Gene Therapy. 9: 591-600. PMID 9525320 DOI: 10.1089/Hum.1998.9.4-591 |
0.41 |
|
| 1998 |
Wang JCY, Lapidot T, Cashman JD, Doedens M, Addy L, Sutherland DR, Nayar R, Laraya P, Minden M, Keating A, Eaves AC, Eaves CJ, Dick JE. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase Blood. 91: 2406-2414. PMID 9516140 DOI: 10.1182/Blood.V91.7.2406.2406_2406_2414 |
0.469 |
|
| 1998 |
Imrie KR, Dubé I, Prince HM, Girouard C, Crump M, Keating A. New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis. Bone Marrow Transplantation. 21: 395-9. PMID 9509975 DOI: 10.1038/Sj.Bmt.1701105 |
0.392 |
|
| 1998 |
Al-Homaidhi A, Prince H, Al-Zahrani H, Doucette D, Keating A. Granulocyte–macrophage colony-stimulating factor-associated histiocytosis and capillary-leak syndrome following autologous bone marrow transplantation: two case reports and a review of the literature Bone Marrow Transplantation. 21: 209-214. PMID 9489640 DOI: 10.1038/Sj.Bmt.1701036 |
0.346 |
|
| 1997 |
Girouard C, Dufresne J, Imrie K, Stewart AK, Brandwein J, Prince HM, Pantolony D, Keating A, Crump M. Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin's lymphoma prior to autologous bone marrow transplantation. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 8: 675-80. PMID 9296221 DOI: 10.1023/A:1008294725992 |
0.358 |
|
| 1997 |
Imrie KR, Sheridan B, Colwill R, Crump M, Stewart AK, McCrae J, Danish R, Sutton D, Romeyer F, Keating A. A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease. Leukemia & Lymphoma. 25: 555-63. PMID 9250827 DOI: 10.3109/10428199709039044 |
0.365 |
|
| 1997 |
Al-Fiar F, Prince HM, Imrie K, Stewart AK, Crump M, Keating A. Bone Marrow Mononuclear Cell Count does not Predict Neutrophil and Platelet Recovery following Autologous Bone Marrow Transplant: Value of the Colony-Forming Unit Granulocyte-Macrophage (CFU-GM) Assay Cell Transplantation. 6: 491-495. DOI: 10.1016/S0963-6897(97)00053-5 |
0.396 |
|
| 1997 |
Crump M, Alhomaidhi A, Imrie K, Stewart A, Brandwein J, Keating A. Low incidence of myelodysplasia (MDS) or acute leukemia (AML) after autologous blood or marrow transplant without total body radiation (TBI) for lymphoma European Journal of Cancer. 33: S93. DOI: 10.1016/S0959-8049(97)84847-2 |
0.368 |
|
| 1997 |
Crump M, Yee K, Imrie K, Couban S, Stewart A, Saragosa R, Keating A. Platelet recovery after high-dose (HD) chemotherapy (C) is superior with peripheral blood stem cells (PBSC) mobilized by C + G-CSF compared to G-CSF alone European Journal of Cancer. 33: S91. DOI: 10.1016/S0959-8049(97)84833-2 |
0.31 |
|
| 1997 |
Tsang RW, Gospodarowicz MK, Sutcliffe SB, Crump M, Keating A. 79 Thoracic radiation therapy (RT) before autologous bone marrow transplantation (ABMT) in relapsed or refractory Hodgkin's disease (HD) International Journal of Radiation Oncology*Biology*Physics. 39: 174. DOI: 10.1016/S0360-3016(97)80636-0 |
0.377 |
|
| 1996 |
Prince HM, Crump M, Imrie K, Stewart AK, Girouard C, Brandwein JM, Carstairs K, Pantalony D, Scott G, Sutcliffe S, Sutton DM, Tsang R, Keating A. Intensive therapy and autotransplant for patients with an incomplete response to front-line therapy for lymphoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 7: 1043-9. PMID 9037363 DOI: 10.1093/Oxfordjournals.Annonc.A010497 |
0.364 |
|
| 1996 |
Matthews KE, Keating A. Bead transfection of adherent cells. Gene transfer into adherent mammalian cells using glass beads. Molecular Biotechnology. 5: 259-61. PMID 8837032 DOI: 10.1007/Bf02900364 |
0.319 |
|
| 1996 |
Imrie K, Dicke KA, Keating A. Autologous bone marrow transplantation for acute myeloid leukemia. Stem Cells (Dayton, Ohio). 14: 69-78. PMID 8820953 DOI: 10.1002/Stem.140069 |
0.455 |
|
| 1996 |
Prince HM, Imrie K, Crump M, Stewart AK, Girouard C, Colwill R, Brandwein J, Tsang RW, Scott JG, Sutton DM, Pantalony D, Carstairs K, Sutcliffe SB, Keating A. The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups. British Journal of Haematology. 92: 880-9. PMID 8616081 DOI: 10.1046/J.1365-2141.1996.437976.X |
0.417 |
|
| 1996 |
Prince HM, Imrie K, Sutherland DR, Keating A, Meharchand J, Crump RM, Girouard C, Trip K, Stewart AK. Peripheral blood progenitor cell collections in multiple myeloma: Predictors and management of inadequate collections British Journal of Haematology. 93: 142-145. PMID 8611448 DOI: 10.1046/J.1365-2141.1996.448987.X |
0.39 |
|
| 1996 |
Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M, Laraya P, Keating A, Eaves A, Lansdorp PM, Eaves CJ, et al. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis Blood. 87: 1539-1548. PMID 8608245 |
0.389 |
|
| 1996 |
Sandhu J, Clark B, Boynton E, Atkins H, Messner H, Keating A, Hozumi N. Human hematopoiesis in SCID mice implanted with human adult cancellous bone Blood. 88: 1973-1982. DOI: 10.1182/Blood.V88.6.1973.Bloodjournal8861973 |
0.378 |
|
| 1996 |
Imrie K, Stewart AK, Crump RM, Prince HM, Trip K, Keating A. Blood Stem Cell Collection: Factors Influencing the Recovery of Granulocyte-Macrophage Colony Forming Cells Cell Transplantation. 5: 379-383. DOI: 10.1016/0963-6897(95)02012-8 |
0.386 |
|
| 1996 |
Greenberger J, Keating A. Keystone Symposium: The Hematopoietic Microenvironment Stem Cells. 14: 366-367. DOI: 10.1002/Stem.140366 |
0.409 |
|
| 1995 |
Crump M, Keating A. Acute leukemia in adults. Current Opinion in Hematology. 2: 247-54. PMID 9372004 DOI: 10.1097/00062752-199502040-00003 |
0.361 |
|
| 1995 |
Clark BR, Keating A. Biology of bone marrow stroma Annals of the New York Academy of Sciences. 770: 70-78. PMID 8597383 DOI: 10.1111/J.1749-6632.1995.Tb31044.X |
0.449 |
|
| 1995 |
Colwill R, Crump M, Couture F, Danish R, Stewart AK, Sutton DM, Scott JG, Sutcliffe SB, Brandwein JM, Keating A. Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 13: 396-402. PMID 7844600 DOI: 10.1200/Jco.1995.13.2.396 |
0.356 |
|
| 1995 |
Stewart AK, Dubé ID, Kamel-Reid S, Keating A. A phase I study of autologous bone marrow transplantation with stem cell gene marking in multiple myeloma. Human Gene Therapy. 6: 107-19. PMID 7703282 DOI: 10.1089/Hum.1995.6.1-107 |
0.443 |
|
| 1995 |
Sutherland DR, Keating A. The CD34 antigen: structure, biology, and potential clinical applications. Journal of Hematotherapy. 1: 115-29. PMID 1285404 DOI: 10.1089/Scd.1.1992.1.115 |
0.405 |
|
| 1994 |
Keating A, Jamieson C, Hornby A, Wang XH, Levy J. Photodynamic elimination of clonogenic Ph+ chronic myeloid leukemia cells. Leukemia & Lymphoma. 265-9. PMID 8251908 DOI: 10.3109/10428199309047897 |
0.365 |
|
| 1994 |
Sutherland DR, Stewart AK, Keating A. CD34 antigen: molecular features and potential clinical applications. Stem Cells (Dayton, Ohio). 50-7. PMID 7507757 DOI: 10.1002/Stem.5530110914 |
0.436 |
|
| 1994 |
Keating A, Wang X, Laraya P. Variable transcription of BCR-ABL by Ph+ cells arising from hematopoietic progenitors in chronic myeloid leukemia [see comments] Blood. 83: 1744-1749. DOI: 10.1182/Blood.V83.7.1744.1744 |
0.309 |
|
| 1993 |
Fang XJ, Keating A, Flowers M, Liew CC, Gupta H, Mills GB, Sherman M. The v-raf oncogene enhances tumorigenicity and suppresses differentiation in vivo in a rat hepatocyte cell line. Carcinogenesis. 14: 669-74. PMID 7682480 DOI: 10.1093/Carcin/14.4.669 |
0.33 |
|
| 1991 |
Stewart K, Schuh A, Keating A. T-Cell Blast Crisis in Chronic Myeloid Leukemia. Leukemia & Lymphoma. 3: 319-24. PMID 27467422 DOI: 10.3109/10428199109070275 |
0.346 |
|
| 1991 |
Brandwein JM, Smith AM, Langley GR, Burnell M, Sutcliffe SB, Keating A. Outcome of Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma Referred for Autologous Bone Marrow Transplantation. Leukemia & Lymphoma. 4: 231-8. PMID 27463042 DOI: 10.3109/10428199109068071 |
0.301 |
|
| 1991 |
Stewart K, Keating A, Sutton D, Scott JG, Francombe W, Carter WH, Baker MA. Adult Acute Lymphoblastic Leukaemia: The Value of Therapy Intensification. Leukemia & Lymphoma. 4: 103-10. PMID 27462939 DOI: 10.3109/10428199109068052 |
0.378 |
|
| 1989 |
Brandwein JM, Callum J, Rubinger M, Scott JG, Keating A. An evaluation of outpatient bone marrow harvesting. Journal of Clinical Oncology. 7: 648-650. PMID 2651579 DOI: 10.1200/Jco.1989.7.5.648 |
0.36 |
|
| 1987 |
Bernstein ID, Singer JW, Andrews RG, Keating A, Powell JS, Bjornson BH, Cuttner J, Najfeld V, Reaman G, Raskind W. Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed. The Journal of Clinical Investigation. 79: 1153-9. PMID 3470307 DOI: 10.1172/Jci112932 |
0.439 |
|
| 1987 |
Blick MB, Andersson BS, Gutterman JU, Keating A, Beran M. The c-abl, bcr and C lambda genes are amplified in a cell line but not in the uncultured cells from a patient with chronic myelogenous leukemia. Leukemia Research. 10: 1401-9. PMID 3099097 DOI: 10.1016/0145-2126(86)90006-8 |
0.3 |
|
| 1987 |
Singer J, Charbord P, Keating A, Nemunaitis J, Raugi G, Wight T, Lopez J, Roth G, Dow L, Fialkow P. Simian virus 40-transformed adherent cells from human long-term marrow cultures: cloned cell lines produce cells with stromal and hematopoietic characteristics Blood. 70: 464-474. DOI: 10.1182/Blood.V70.2.464.464 |
0.419 |
|
| 1986 |
Toneguzzo F, Keating A. Stable expression of selectable genes introduced into human hematopoietic stem cells by electric field-mediated DNA transfer. Proceedings of the National Academy of Sciences of the United States of America. 83: 3496-9. PMID 3458192 DOI: 10.1073/Pnas.83.10.3496 |
0.398 |
|
| 1986 |
Wight T, Kinsella M, Keating A, Singer J. Proteoglycans in human long-term bone marrow cultures: biochemical and ultrastructural analyses Blood. 67: 1333-1343. DOI: 10.1182/Blood.V67.5.1333.Bloodjournal6751333 |
0.325 |
|
| 1985 |
Rosenfeld M, Keating A, Bowen-Pope DF, Singer JW, Ross R. Responsiveness of the in vitro hematopoietic microenvironment to platelet-derived growth factor. Leukemia Research. 9: 427-34. PMID 2987621 DOI: 10.1016/0145-2126(85)90001-3 |
0.339 |
|
| 1985 |
Charbord P, Gown A, Keating A, Singer J. CGA-7 and HHF, two monoclonal antibodies that recognize muscle actin and react with adherent cells in human long-term bone marrow cultures Blood. 66: 1138-1142. DOI: 10.1182/Blood.V66.5.1138.1138 |
0.33 |
|
| 1984 |
Singer JW, Keating A, Cuttner J, Gown AM, Jacobson R, Killen PD, Moohr JW, Najfeld V, Powell J, Sanders J. Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: studies of patients with clonal hematopoietic neoplasia. Leukemia Research. 8: 535-45. PMID 6471898 DOI: 10.1016/0145-2126(84)90002-X |
0.372 |
|
| 1983 |
Singer J, Keating A, Ramberg R, McGuffin R, Sanders J, Sale G, Fialkow P, Thomas E. Long-term stable hematopoietic chimerism following marrow transplantation for acute lymphoblastic leukemia: a case report with in vitro marrow culture studies Blood. 62: 869-872. DOI: 10.1182/Blood.V62.4.869.869 |
0.454 |
|
| 1982 |
Keating A, Singer JW, Killen PD, Striker GE, Salo AC, Sanders J, Thomas ED, Thorning D, Fialkow PJ. Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature. 298: 280-3. PMID 6806668 DOI: 10.1038/298280A0 |
0.481 |
|
| Show low-probability matches. |